Subscribe to Newsletter

Search

Reset Filter

3786 search results for ‘*’

Manufacture Advanced Medicine

Mastering The Complexity Of CGT Process Development - How To Meet Challenges On The Path To Commercialization

, 05:00 PM CET | Sponsored by Miltenyi Biotec

Check Out The Roundtable Discussion Featuring Four Experts From Miltenyi Biotech


Manufacture Packaging

Understanding the Benefits of BFS Unidose for Ophthalmics as an Alternative to Glass Vials

, 03:00 PM CET | Sponsored by ReciPharm

Blow-Fill-Seal Technology Is A Promising Container Format; Experts From Recipharm Explain Why

Business & Regulation Business Practice

Video Interview: The High Costs of Advanced Therapies, Part 1

| Stephanie Vine

Cardinal Health’s Fran Gregory talks about the high costs of cell and gene therapies, and what this means for payers.

Manufacture Technology and Equipment

Getting Insight from the Factory Floor

| Nic Azad | 5 min read

Why not use technology to find out what is going wrong on the factory floor – and why it is affecting supply chains?

Business & Regulation Profession

Talent Spotting in Pharma

| Stephanie Vine | 5 min read

Have you noticed a shortage of skilled individuals entering the pharma industry?

Discovery & Development Technology and Equipment

Cooking, Computing, and Collaborating

Sitting Down With Christian Baber of the Pistoia Alliance

Business & Regulation Standards & Regulation

Showdown Over the Abortion Pill in the US

| Stephanie Vine | 4 min read

The Supreme Court will decide the fate of the abortion pill mifepristone in the US on March 26, 2024.

Manufacture Bioprocessing - Upstream & Downstream

Pool Power

| Simon Keen, Brett Verstak | 4 min read

Why is the stable pools approach attracting more attention in the cell line development space?

Discovery & Development Ingredients

DEG Contamination: We Must Keep Eyes on Supply

| Stephanie Vine | 10 min read

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

Discovery & Development Drug Discovery

Biologically Driven

| 4 min read

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register